Hyperglycemia and hypertriglyceridemia appear to be strongly linked to the increase in IL-13, which suggest a novel role of this cytokine in the regulation of glucagon-dependent pathways and lipolysis that should be addressed in patients at higher cardiovascular risk such as the vast majority of individuals living with insulin resistance, metabolic syndrome, and T2D. The gene discussed is IL13; the disease is Insulin resistance.